"Neuromod secures €10m to expand tinnitus treatment device’s availability" was originally created and published by Medical ...

Irish medtech group Neuromod Devices has raised €10 million equity financing to expand the availability of its tinnitus ...

Dublin-based Neuromod has raised €10.5m and plans to further fuel Lenire's commercialisation in Europe and reach US veterans.

Neuromod Devices announced today that it closed an equity financing round worth proceeds of about $10.9 million (€10 million) ...

Irish medtech company Neuromod has raised €10m in equity financing to expand the production of Lenire – a device that helps ...

Neuromod has closed a €10m round of equity financing as it looks to expand the availability of its tinnitus treatment device ...

Neuromod Devices Ltd. raised €10 million (US$10.9 million) in financing to expand the reach of Lenire, which treats tinnitus.

Neuromod Devices Ltd. (Neuromod), an Irish medical device company specialising in tinnitus, has successfully closed a €10 million equity financing to expand the availability of its tinnitus treatment ...

Irish medical device company Neuromod Devices has received €10m ($10.8m) in equity financing to broaden the reach of Lenire, its tinnitus treatment device. Current investors Panakès Partners ...

In June 2024, Neuromod was awarded a Federal Supply Schedule 65 II Medical Equipment and Supply Contract from the US Government, making Lenire a treatment option for the 2.9 million US Veterans ...

Neuromod has been making Lenire available through audiology and ENT practices throughout the USA and Europe. Proceeds from the financing will be used to meet demand for Lenire through sustainable ...